SUCCINYLCHOLINE CHLORIDE

Generic: SUCCINYLCHOLINE CHLORIDE

Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
SUCCINYLCHOLINE CHLORIDE DIHYDRATEActive Substance
2020-06-12Original Approval

SUCCINYLCHOLINE CHLORIDE is FDA application ANDA213229, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2025-08-27
Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufacture

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any ind

Top Reported Reactions

1
DRUG INEFFECTIVE
227 reports
2
HYPOTENSION
173 reports
3
CARDIAC ARREST
158 reports
4
ANAPHYLACTIC SHOCK
143 reports
5
DRUG INTERACTION
125 reports
6
ANAPHYLACTIC REACTION
109 reports
7
RENAL FAILURE
99 reports
8
RENAL IMPAIRMENT
98 reports
9
PAIN
96 reports
10
HYPERTHERMIA MALIGNANT
95 reports